Hormone receptor-positive breast cancer is the most common subtype of breast cancer in all the stages of advancement. Hormone therapy, as one of the elements of breast cancer therapy, considerably influences this type of cancer patients’ future. The case described below is an example of treatment of a patient with hormone receptor-positive cancer when hormone medicines with different mechanisms of action were used at each stage of treatment. These medicines while preserving patients quality of life improve time to progression and overall survival.Hormonalnie pozytywny nowotwór złośliwy piersi stanowi najczęściej występujący podtyp raka piesi we wszystkich stopniach zaawansowania. Leczenie hormonalne, jako jeden z elementów terapii raka pier...
Fulwestrant jest selektywnym antagonistą receptora estrogenowego pozbawionym częściowej aktywności a...
With constant improvement of medicine we can diagnose and treat breast cancer in more and more effec...
Breast cancer is the most common cancer among Polish women. Every year around 5000 women dies due to...
The choice of treatment modality in metastatic breast cancer depends on an age, performance status o...
There is strong evidence that endocrine therapy is the preferred option for hormone receptor positiv...
Breast cancer is the most frequent cancer in women and the second cause of cancer-related deaths in ...
About 75% of breast cancers are estrogen receptor-positive. Approximately 10% of them is HER2-positi...
The maintenance chemotherapy in patients with advanced breast cancer is still a matter of controvers...
Breast cancer is the most common women neoplasm. Despite standard primary treatment, there are quite...
Breast cancer is the most common malignancy of women. Progress in screening mammography and adjuvant...
Rak piersi jest najczęstszym kobiecym nowotworem złośliwym, w związku z czym stanowi bardzo istotny ...
Breast cancer is the most common caner occurring in women in Poland.Hormone therapy in palliative tr...
Breast cancer is the most common cancer between women. It is the most common cancer among residents ...
Capecitabine monotherapy represents an effective and feasible option in heavily pretreated women wit...
Rak piersi jest najczęstszym nowotworem złośliwym u kobiet w Polsce. Wyniki leczenia tego nowotworu ...
Fulwestrant jest selektywnym antagonistą receptora estrogenowego pozbawionym częściowej aktywności a...
With constant improvement of medicine we can diagnose and treat breast cancer in more and more effec...
Breast cancer is the most common cancer among Polish women. Every year around 5000 women dies due to...
The choice of treatment modality in metastatic breast cancer depends on an age, performance status o...
There is strong evidence that endocrine therapy is the preferred option for hormone receptor positiv...
Breast cancer is the most frequent cancer in women and the second cause of cancer-related deaths in ...
About 75% of breast cancers are estrogen receptor-positive. Approximately 10% of them is HER2-positi...
The maintenance chemotherapy in patients with advanced breast cancer is still a matter of controvers...
Breast cancer is the most common women neoplasm. Despite standard primary treatment, there are quite...
Breast cancer is the most common malignancy of women. Progress in screening mammography and adjuvant...
Rak piersi jest najczęstszym kobiecym nowotworem złośliwym, w związku z czym stanowi bardzo istotny ...
Breast cancer is the most common caner occurring in women in Poland.Hormone therapy in palliative tr...
Breast cancer is the most common cancer between women. It is the most common cancer among residents ...
Capecitabine monotherapy represents an effective and feasible option in heavily pretreated women wit...
Rak piersi jest najczęstszym nowotworem złośliwym u kobiet w Polsce. Wyniki leczenia tego nowotworu ...
Fulwestrant jest selektywnym antagonistą receptora estrogenowego pozbawionym częściowej aktywności a...
With constant improvement of medicine we can diagnose and treat breast cancer in more and more effec...
Breast cancer is the most common cancer among Polish women. Every year around 5000 women dies due to...